Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiolabeled BC8 Combined With Cyclophosphamide and TBI Followed by Stem Cell Transplantation for Advanced AML and MDS
NCT00003868Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Feb 1999
- Primary completion
- Mar 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of apamistamab in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Fred Hutchinson Cancer Center. Started Feb 1999; status: completed.
02
Drugs
apamistamab
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00003868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003868.